<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/55015EF3-7E02-4B8E-A4D8-7C7092D731DF"><gtr:id>55015EF3-7E02-4B8E-A4D8-7C7092D731DF</gtr:id><gtr:name>Canary Foundation</gtr:name><gtr:address><gtr:line1>PO Box 54146</gtr:line1><gtr:postCode>CA 95154</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/55015EF3-7E02-4B8E-A4D8-7C7092D731DF"><gtr:id>55015EF3-7E02-4B8E-A4D8-7C7092D731DF</gtr:id><gtr:name>Canary Foundation</gtr:name><gtr:address><gtr:line1>PO Box 54146</gtr:line1><gtr:postCode>CA 95154</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7EA7E476-F8CD-4A75-9746-0058BEC86C92"><gtr:id>7EA7E476-F8CD-4A75-9746-0058BEC86C92</gtr:id><gtr:firstName>Rebecca</gtr:firstName><gtr:surname>Fitzgerald</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12022%2F2"><gtr:id>00CB19BB-7E41-4106-825F-5D5D8501FA55</gtr:id><gtr:title>Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12022/2</gtr:grantReference><gtr:abstractText>Cancer of the gullet (oesophagus) is increasing rapidly in the western world and has a very poor outcome unless diagnosed early. My research laboratory is focussed on better understanding how this cancer develops so that we can find better tools for diagnosis and treatment. We have made very good progress in developing a new diagnostic test called the Cytosponge. This comprises a cell collection device which can be given in the GP surgery and avoids endoscopy. The collected cells are then tested in the laboratory for protein and gene alterations that we have identified suggestive of precancerous changes. This test is now being developed for routine clinical use.</gtr:abstractText><gtr:technicalSummary>Understand the underlying clinical, genetic and cell environmental factors that lead to the conversion of a low-risk pre-malignant state into invasive cancer.
Find new diagnostic tools that will identify those patients who are at an increased risk of developing cancer.
Improve the molecular characterisation of oesophageal adenocarcinoma and identify novel approaches for tumour classification, monitoring and therapy.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2863000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Canary Foundation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Participating in Don Listwin visit (Founder, Chairman, CEO, Canary Foundation)</gtr:description><gtr:id>B8FC4C3D-5C1E-4859-A404-F3CF01B1C6D0</gtr:id><gtr:impact>The collaboration is still in the inception stages so no outcomes to report yet.</gtr:impact><gtr:outcomeId>58b95b9970b1c8.07280828-1</gtr:outcomeId><gtr:partnerContribution>Don Listwin seeks to establish a collaborative framework trhough which commom research goals can be funded and realised</gtr:partnerContribution><gtr:piContribution>Professor Fitzgerald met Don Listwin (Founder, Chairman, CEO, Canary Foundation) on behalf of the Cambridge Cancer Centre (CCC) to showcase research and to discuss prospects of joint ventures and funding opportunities for the Early Detection Programme of the CCC.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>News coverage of BEST3 trial in Cambridge News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1700EB7C-D842-4629-AFD5-9D145AB787BD</gtr:id><gtr:impact>A news article was published in Cambridge News, which raised awareness of funding awarded to the MRC Cancer Unit (Fitzgerald group) for a new trial of 4,000 patients in GP practices to see if a new test (Cytosponge) can detect the earliest stages of cancer. This article raised awareness of the dangers associated with persistent heartburn and communicated information on this trial to prospective patients.</gtr:impact><gtr:outcomeId>56c5cdeccf2e01.52426344</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Doctors-warn-persistent-heartburn-Cambridge/story-28363767-detail/story.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Channel 4 television</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A2B48FAE-E2A0-47B5-87FA-55EFFF4BE0A3</gtr:id><gtr:impact>Cytosponge device appeared on C4's Embarrassing Bodies bodies, along with information on risks of heartburn and cancer

Increased awareness of risk associated with heartburn and of new diagnostic device</gtr:impact><gtr:outcomeId>543e50b81884f3.94623360</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Boots WebMD news story</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1BB984CD-431D-4116-88DF-5A2402BE1753</gtr:id><gtr:impact>News coverage in Boots WebMD; a online leading source for trustworthy and timely health and medical news and information. Improved awareness of risks associated with oesophageal cancer and of uses of the Cytosponge device.

Increased public awareness of the Cytosponge device for detection of early changes associated with oesophageal cancer.</gtr:impact><gtr:outcomeId>55d2e679aa9699.33213240</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.webmd.boots.com/cancer/news/20150721/sponge-diagnoses-cancer</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NCRI Cancer Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AB4E20CA-EDE8-4095-A3D4-2E25B22C6508</gtr:id><gtr:impact>Gave a presentation on Early Detection and Prevention and was a table host on Clinical Scientist Careers in the Women in Science workshop</gtr:impact><gtr:outcomeId>58b836a0b866c6.23128349</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://conference.ncri.org.uk/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with BBC Radio Cambridgeshire</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B37D8115-736D-4B66-9494-3AAC99B54B7A</gtr:id><gtr:impact>Informed public of new research and increase awareness of risks associated with heartburn.

Increased awareness of Cytosponge device for Barretts oesophagus.</gtr:impact><gtr:outcomeId>55c48b022895c8.21540919</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dinner event at Pembroke College in honour of Roy Quek  (Executive Chairman of Thomson Medical Centre Ltd)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4F069EB6-7397-47C2-B1A4-4433665FA7BD</gtr:id><gtr:impact>Professor Fitzgerald attended this networking event as a representative oft he Clinical School by invitation of the Regius Professor of Physic and Head of the School of Clinical Medicine of the University of Cambridge. The event was instrumental in scouting for opportunities and initiating funding and research collaboration related plans between both organisations</gtr:impact><gtr:outcomeId>58b96033d777a5.99206232</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News coverage of Nature publication and Cytosponge device in BBC News Online.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5CE94A80-BE86-400B-B9F1-FC0881BC8A3B</gtr:id><gtr:impact>Online coverage of Nature publication and Cytosponge device by BBC news. Improved awareness of risks associated with oesophageal cancer and of the uses of the Cytosponge device.</gtr:impact><gtr:outcomeId>56ab96dd2d5b93.56237142</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-29877701</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with local ITV News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AEF6C31D-94CA-4E61-BD72-F06389E373A7</gtr:id><gtr:impact>Informed public of new research and increased awareness of risks associated with heartburn.

Informed public of the Cytosponge device for Barrett's oesophagus.</gtr:impact><gtr:outcomeId>55c48bdb362348.82893481</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News coverage of Nature publication and Cytosponge device in Newsweek.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CDEC82DF-4404-4E70-B710-1F71253334E7</gtr:id><gtr:impact>News coverage in a Newsweek magazine. Improved awareness of risks associated with oesophageal cancer and of the uses of the Cytosponge device.

Increased public awareness of the Cytosponge device for detection of early changes associated with oesophageal cancer.</gtr:impact><gtr:outcomeId>55d2e487a0c1e9.52421970</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://europe.newsweek.com/pill-string-could-save-thousands-lives-early-cancer-diagnosis-330559</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cam Uni press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7C5BFDD7-9F19-43E0-8755-62608DAC3F98</gtr:id><gtr:impact>Cambridge University press release on research discovery

Increased awareness of research and its impact, as release was picked up several national and international outlets</gtr:impact><gtr:outcomeId>543e503933dba7.58504500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/research/news/oesophageal-cancer-gene-identified</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge News news story</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FDCBBD51-ACF9-4356-B352-351F13DF2DC2</gtr:id><gtr:impact>News coverage in Cambridge News. Improved awareness of risks associated with oesophageal cancer and of the uses of the Cytosponge device.

Increased public awareness of the Cytosponge device for detection of early changes associated with oesophageal cancer.</gtr:impact><gtr:outcomeId>55d2e27108e962.79106123</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/New-Cambridge-throat-cancer-diagnosis-swallowed/story-27448851-detail/story.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News coverage in Cambridge News to coincide with World Cancer Day</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3488CC85-7CB8-4DF4-BD1F-94D84F94AF21</gtr:id><gtr:impact>A news article featured in Cambridge News to coincide with World Cancer Day. The article describes the support networks, new equipment and facilities that are now available to patients presenting to Addenbrookes Hospital with cancer. It also describes the Early Detection Programme, the research projects around this, the Cytosponge, and other ways in which researchers are looking to detect cancer at its earliest stages (at the MRC Cancer Unit). This article raised awareness of the facilities, services and ongoing research in cancer at Addenbrookes Hospital and the MRC Cancer Unit.</gtr:impact><gtr:outcomeId>56c70ca947c4c4.65119443</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/World-Cancer-Day-state-cancer-care-Cambridge/story-28666014-detail/story.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News coverage of the Early Detection Programme (and funding awarded to support this) in Cambridge News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>075DBDA8-2E07-4C55-8570-1C458942CA52</gtr:id><gtr:impact>A news article was published in Cambridge News to communicate the Early Detection Programme at CRUK-CI and Addenbrookes/Rosie Hospital, as well as funding that has been received from CRUK to support this programme. This raised awareness of the importance of early detection of cancer as well as the research that is being undertaken by Prof Rebecca Fitzgerald in this field.</gtr:impact><gtr:outcomeId>56c7077eb33ee2.43821710</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/New-research-programme-Cambridge-help-detect/story-28580097-detail/story.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Telegraph News Story</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6CA79D3C-2474-4D95-A9C9-F1151C5984EF</gtr:id><gtr:impact>News coverage in Daily Telegraph. Improved awareness of risks associated with oesophageal cancer and of the uses of the Cytosponge device.

Increased public awareness of the Cytosponge device for detection of early changes associated with oesophageal cancer.</gtr:impact><gtr:outcomeId>55c48f51bdd373.86325705</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.telegraph.co.uk/news/health/news/11751447/Pill-on-a-string-can-detect-cancer-without-need-for-biopsy.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News story in Gizmag</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4B7FC836-333E-4DE5-B796-C21067708F3E</gtr:id><gtr:impact>News coverage in Gizmag online publication. Improved awareness of risks associated with oesophageal cancer and of the uses of the Cytosponge device.

Increased public awareness of the Cytosponge device for detection of early changes associated with oesophageal cancer.</gtr:impact><gtr:outcomeId>55d2e56b141005.57842563</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.gizmag.com/pill-string-cancer-stomach/38547/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participation in Cambridge University Science Festival (2015-16)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4B3C99BD-9FE5-406D-9ED6-FE3C9A640F19</gtr:id><gtr:impact>The Cambridge Science Festival aims to reach out to the general public and communicate about the different aspects of science and research being undertaken at the University. It is a free event, over two weeks, with an excess of 270 events and more than 30000 attendees. As part of this, the MRC CU along with the CRUK CI organised a set of talks and activities that were attended by over 100 people from all walks of life - from young children and young adults to parents/carers and professionals. The Fitzgerald lab was part of the MRC CU team at this event. The event generated a lot of interest in cancer research, helped raise awareness about the importance of 'early' in cancer which is the mission of the MRC CU and also led to a lot of interest being generated in the MRC Festival of Science which followed on later in the year.</gtr:impact><gtr:outcomeId>58b6f0ec3c0f98.62966831</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/events?search_api_views_fulltext=cancer</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Expert panellist in the first ever cancer-related event to form part of the Cambridge University Festival of Ideas:</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7F3B3087-B6E4-4A91-AA11-79AB1DCF590F</gtr:id><gtr:impact>On 24th October a packed audience gathered at the McCrum lecture theatre in the heart of Cambridge to attend the Festival of Ideas event &amp;quot;Is earlier necessarily better?&amp;quot; This was the first ever cancer-themed event to feature in the Festival of Ideas, which generally focuses more on the arts and social sciences. The premise of the event was to explore the wider, societal issues surrounding cancer screening (psychological, social, economic, philosophical). This is an under-researched area currently being explored by the Early Detection Programme.
The event itself featured a panel of seven experts from across the academic disciplines including law, history and philosophy of science, radiology, cancer genetics and surgery. Chaired by cancer geneticist Prof Sir Bruce Ponder, the panel and audience were inspired to discussion using clips from the BBC Horizon programme episode entitled 'Are health tests really a good idea'? The audience engagement was informed and thought provoking, resulting in a very stimulating cross-disciplinary exchange of views and ideas.</gtr:impact><gtr:outcomeId>58b82ca9dac876.80578637</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.festivalofideas.cam.ac.uk/events/earlier-necessarily-better</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Daily Mail news story</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>57D0A44D-A3B8-4A95-B7CD-828CD6292641</gtr:id><gtr:impact>Publication in Daily Mail Online. Increased awareness of early diagnosis/prevention of oesophageal cancer.

Informed public of new research and the Cytosponge device for detecting early changes associated with oesophageal cancer.</gtr:impact><gtr:outcomeId>55c48d0b16f968.36796124</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/health/article-3168433/Swallowing-sponge-string-diagnose-throat-cancer-Tiny-Brillo-pad-detects-telltale-signs-disease-passes-gullet.html#ixzz3gVkEvM1E</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participation in MRC Festival of Science Open Day 2016 at MRC CU</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FA8824B9-6DD6-4FDB-8360-3FC394F5F04C</gtr:id><gtr:impact>60 sixth-form students from across 8 schools in Cambridge visited the MRC Cancer Unit on the afternoon of the 22nd of June, 2016 for an Open Day. All students, accompanied by their teachers, were given a tour of the enitre building with an opportunity for engaging with researchers about the state of the art in cancer research and gaining hands-on experience with setting up experiments. Talks about career opportunities and challenges associated with pursuing cancer research were also available to all attendees. The event sparked a great deal of interest and enthusiasm in students and teachers alike and we have had a request for this event to be continued. We will be pursuing a similar format of activities for the MRC Science Festival in 2017, but reach out to more number of schools, including those outside of Cambridge city perimeters.</gtr:impact><gtr:outcomeId>58b6f15403fe30.29321411</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://mrccancerunit.wordpress.com/2016/07/06/inspiring-the-next-generation-of-cancer-researchers-the-mrc-cancer-unit-open-day-2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>00CDAC33-C39A-4643-BF70-09BFD9D96E25</gtr:id><gtr:impact>Researchers discussed their work and coordinated activities for the public such as DNA extraction.

Increased awareness of cancer research and its importance</gtr:impact><gtr:outcomeId>543e4fb9dd92e0.88615847</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science plenary talk for Institute of Continuing Education</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9359D85D-0314-44B6-A04C-C6BB19A6CAD9</gtr:id><gtr:impact>Gave an educational talk on cancer research for school teachers to a large audience</gtr:impact><gtr:outcomeId>58b961600b9b60.63703637</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival Talk:  Does a pill on a string hold the answer for earlier diagnosis of oesophageal cancer?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4E72CA5F-8653-4942-9771-000DF0382160</gtr:id><gtr:impact>This talk was given as part of the Cambridge Science Festival 2016. Through her talk, 'Does a pill on a string hold the answer for earlier diagnosis of oesophageal cancer?' Professor Rebecca Fitzgerald, described the 10-year journey to develop the Cytosponge test and what it takes to get such a simple idea into the clinic. Her talk highlighted and sparked interest about one of the biggest problems faced by patients and practitioners in cancer cure- late diagnosis.</gtr:impact><gtr:outcomeId>58b595e59299b8.44326668</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/news/insights-finding-cure-cancer</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>22185</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ACT</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Addenbrooke's Hospital</gtr:fundingOrg><gtr:fundingRef>LCC/13/14 D</gtr:fundingRef><gtr:id>2F782788-EA02-4306-B562-559429D44787</gtr:id><gtr:outcomeId>545f3521bdba51.82761854</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>289313</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research UK - China Study</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C14478/A18119</gtr:fundingRef><gtr:id>219ED159-2D8B-4603-948A-CC4D50ABBC4C</gtr:id><gtr:outcomeId>545f3612c96069.70226162</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14448</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Univ North Carolina-non endoscopic surveillence-Barretts Esophagus</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>University of North Carolina at Chapel Hill</gtr:fundingOrg><gtr:id>A04B0FAA-ACF2-4F55-91AF-39214EE932F2</gtr:id><gtr:outcomeId>56d5b3563ca312.75187670</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214872</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK - CLINICAL TRAINING AWARD CYCLE 2 (A K-S)</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>D64B4FE4-AA07-4BA6-8C35-2B65557A1661</gtr:id><gtr:outcomeId>56d5b5c1e21e82.21297329</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>289313</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project grant</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>7D7B2BA9-52CA-46A3-8EC5-F71FF6EBFD82</gtr:id><gtr:outcomeId>558981733e3140.11392188</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22185</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Addenbrooke's Charitable Trust (Massi Di Pietro)</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>D6BE0ED5-4F1C-4E45-98C3-A8CD9E196C20</gtr:id><gtr:outcomeId>56d5bc83d29562.75350278</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>UEG Prize</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>United European Gastroenterology</gtr:fundingOrg><gtr:id>16C1B7A1-2B55-45F2-9E82-62860A9DA38E</gtr:id><gtr:outcomeId>545f36b58d53e0.94954169</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant - Cambridge-Manchester Imaging Centre</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>D903DD64-50F9-441B-B664-7434BF1F5C27</gtr:id><gtr:outcomeId>56d5b4d855c3b9.15304543</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30939</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge University Hospitals (CUH) - Research Capability</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Addenbrooke's Hospital</gtr:fundingOrg><gtr:id>1055E13F-40FC-4922-B123-D485AB0466EB</gtr:id><gtr:outcomeId>56d5b567e0f5a1.44890644</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9091</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Univ North Carolina - Diagnosis and Monitoring</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>University of North Carolina at Chapel Hill</gtr:fundingOrg><gtr:id>D3AA946D-78FC-4EF2-852C-84D9543556A3</gtr:id><gtr:outcomeId>56d5b4402226b8.36456079</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>77640</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Univ N Carolina - Stratifying Risk in Barretts Esophagus</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>University of North Carolina at Chapel Hill</gtr:fundingOrg><gtr:id>9D181A69-C4C4-4B30-9A23-6D3627CAD079</gtr:id><gtr:outcomeId>56d5b40579bf86.33626027</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55253</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EBPOD Fellow - Sarah Killcoyne</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:fundingOrg><gtr:id>B3CA13AA-7B63-4730-A5C6-8D609916A050</gtr:id><gtr:outcomeId>56d5bd0dedcb52.15959416</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Clinical Research Facilities</gtr:department><gtr:description>Queen Mary University Project Grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Queen Mary University of London</gtr:fundingOrg><gtr:fundingRef>13/WA/0151</gtr:fundingRef><gtr:id>88CDE59A-1E3F-41FE-B1DE-75014378C928</gtr:id><gtr:outcomeId>545f37824572f0.61804530</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6548</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Univ North Carolina - Non-endoscopic surveillance for Barretts Esophagus</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>University of North Carolina at Chapel Hill</gtr:fundingOrg><gtr:id>9CDF40C2-B3FB-4BF2-9A8E-776E6E665241</gtr:id><gtr:outcomeId>56d5b3b368cb69.84173590</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160131</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CCC PhD Studentship-RFE</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>6A782ED3-553F-4C7D-866B-39B88F2E749F</gtr:id><gtr:outcomeId>cNWzELVbtEu</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participated in HCUK Trustees meeting (Heartburn Cancer UK)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1006ED8B-E2A5-4143-89ED-42D1E9B2524C</gtr:id><gtr:impact>Progessor Fitzgerald has contributed in Trustees meetings towards policies that are aimed to improve awareness amongst the general public and doctors about heartburn and the link with Barrett's oesophagus and cancer</gtr:impact><gtr:outcomeId>58b82ed74ed613.04943564</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.heartburncanceruk.org/theteam.html</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>policy workshop on the future of Genomic Medicine (Trinity Hall, Cambridge) The Future of Genomic Medicine Patents in Europe and the US: beyond Sequenom, Prometheus, Monsanto &amp;amp; FLT3</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>804374D7-06EC-4370-8BAF-18F2C34BDC17</gtr:id><gtr:outcomeId>58b8282de17ba6.77158813</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.csap.cam.ac.uk/events/future-genomic-medicine-patents-europe-and-us/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E3C8CB47-A8E3-4D11-B7C4-8916471950F1</gtr:id><gtr:title>Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular gastroenterology and hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2352-345X</gtr:issn><gtr:outcomeId>5a8d8c1c534d78.44511405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B71783FA-FDA0-4CA3-804D-B98489D02FC8</gtr:id><gtr:title>Cancer development: Origins in the oesophagus.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dffc4486c017fe0b7de61b20b08081a7"><gtr:id>dffc4486c017fe0b7de61b20b08081a7</gtr:id><gtr:otherNames>Zhuang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a8d8c5a9b8646.71569956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BE97987-5015-427A-88A8-9606F902DA9B</gtr:id><gtr:title>Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>5a8d8d86e830a8.13134265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E2C4AE8-0F27-4979-8DD7-9ADD4161688A</gtr:id><gtr:title>Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51369dd875ec772c77b28c7d2865e351"><gtr:id>51369dd875ec772c77b28c7d2865e351</gtr:id><gtr:otherNames>Buas MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>58b45534170300.81966737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B6BEB98-A914-4DFD-9F44-D2D9684B86CC</gtr:id><gtr:title>Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d197922d41d0d4fcf03087dacd7bc40"><gtr:id>1d197922d41d0d4fcf03087dacd7bc40</gtr:id><gtr:otherNames>Chettouh H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5a8d8b7052c5f7.29034422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79B3FE6C-A622-48B6-A492-69286E5D4BE5</gtr:id><gtr:title>Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/374f58aed2c059b62f2efd7a5fea2b87"><gtr:id>374f58aed2c059b62f2efd7a5fea2b87</gtr:id><gtr:otherNames>Weaver JMJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5436a476945004.40300873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0177C515-4558-475C-A0DE-1C7199D8F801</gtr:id><gtr:title>IRES-Mediated Protein Translation Overcomes Suppression by the p14ARF Tumor Suppressor Protein.</gtr:title><gtr:parentPublicationTitle>Journal of Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92964e7dedb4b29e9ebe2af034d353c2"><gtr:id>92964e7dedb4b29e9ebe2af034d353c2</gtr:id><gtr:otherNames>Xi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1837-9664</gtr:issn><gtr:outcomeId>5a8d8f25d63d49.20720879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C0F8576-C342-4BC2-AE23-6CF1F25D130C</gtr:id><gtr:title>Research advances in esophageal diseases: bench to bedside.</gtr:title><gtr:parentPublicationTitle>F1000prime reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-7599</gtr:issn><gtr:outcomeId>5436a4788ee611.96847714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6002CAD8-F31C-473E-AC25-F1533E641D57</gtr:id><gtr:title>Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5a8d95ed9db359.38239250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CEFD5BC-04B2-4DC9-BEFB-9A670C3096CC</gtr:id><gtr:title>Screening for Barrett's Esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>55897f67eb7363.28926643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8441FCCF-BD1D-4710-98E5-A80CFE7F4B41</gtr:id><gtr:title>Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Endoscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5511939e955cc822ab9baf4fcc2021ef"><gtr:id>5511939e955cc822ab9baf4fcc2021ef</gtr:id><gtr:otherNames>Shariff MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-726X</gtr:issn><gtr:outcomeId>5661a2d174cf11.46490168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E9929BA-FFB5-4049-B020-C0D1CCC82664</gtr:id><gtr:title>The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4df2be14a0c62d43a892f34bb17150"><gtr:id>9b4df2be14a0c62d43a892f34bb17150</gtr:id><gtr:otherNames>Barbera M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5436a4782e6e14.02518472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5BD4EB9-A741-47C1-92D5-B7A4F5BE8F76</gtr:id><gtr:title>Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.</gtr:title><gtr:parentPublicationTitle>Gastrointestinal endoscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de14b639cc54247b2d3e4035c7848c9b"><gtr:id>de14b639cc54247b2d3e4035c7848c9b</gtr:id><gtr:otherNames>Lim YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-5107</gtr:issn><gtr:outcomeId>5436a4785ca5b1.39375836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EFE1ABA-BED7-43A0-A24C-9F63DA04F902</gtr:id><gtr:title>Biomarkers for dysplastic Barrett's: ready for prime time?</gtr:title><gtr:parentPublicationTitle>World journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2eba2753aefd9071b33316779022ede0"><gtr:id>2eba2753aefd9071b33316779022ede0</gtr:id><gtr:otherNames>Gregson EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-2313</gtr:issn><gtr:outcomeId>5436a4770f0b27.84279417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>873E0D95-F22C-4105-A0F0-64C547E185A0</gtr:id><gtr:title>Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5436a477a98d20.80896702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74932598-E336-435E-8912-CC2A1BF24B5D</gtr:id><gtr:title>The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Annals of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0709b553591693980068d284b28cb8fc"><gtr:id>0709b553591693980068d284b28cb8fc</gtr:id><gtr:otherNames>Worster E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-4932</gtr:issn><gtr:outcomeId>56c71075794eb9.90416314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF373364-7147-4314-9F34-5C3C8AA19182</gtr:id><gtr:title>Barrett's Esophagus</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34ab93e9109520a74e02f01f1ef2d777"><gtr:id>34ab93e9109520a74e02f01f1ef2d777</gtr:id><gtr:otherNames>Katz-Summercorn A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>9780128025116</gtr:isbn><gtr:outcomeId>58b458cc337a72.02242094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>784CEE04-7695-4D4F-840B-EE30B40208B4</gtr:id><gtr:title>Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e26b2f9faa40fa69db9b591be1874214"><gtr:id>e26b2f9faa40fa69db9b591be1874214</gtr:id><gtr:otherNames>van der Post RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>55897f6792acf6.99563743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD34823-0895-4240-90E0-93001516E00A</gtr:id><gtr:title>Fluorescence imaging for the detection of early neoplasia in Barrett's esophagus: old looks or new vision?</gtr:title><gtr:parentPublicationTitle>European journal of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef204e0e878695b8ed044ba71c336143"><gtr:id>ef204e0e878695b8ed044ba71c336143</gtr:id><gtr:otherNames>Boerwinkel DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-691X</gtr:issn><gtr:outcomeId>5436a476ce34b1.20828994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>370D1B1B-0185-4260-AEE9-471EDD5A2EA8</gtr:id><gtr:title>A review of the current understanding and clinical utility of miRNAs in esophageal cancer.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce78660e2f710a4fb2aec735819d3610"><gtr:id>ce78660e2f710a4fb2aec735819d3610</gtr:id><gtr:otherNames>Sakai NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>5436a4793c36b5.64789212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFDBBE1D-0C9C-443D-80BA-366C07D58E0A</gtr:id><gtr:title>DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f17ac07c973c84943fa207facf1e836"><gtr:id>1f17ac07c973c84943fa207facf1e836</gtr:id><gtr:otherNames>Alvi MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>pm_13321_21_23243219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B34531E2-108B-4364-942D-E3E3E7E49A0E</gtr:id><gtr:title>An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).</gtr:title><gtr:parentPublicationTitle>Familial cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aaf33a3b06fc83c83a3eca5d90bd596"><gtr:id>4aaf33a3b06fc83c83a3eca5d90bd596</gtr:id><gtr:otherNames>Hallowell N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1389-9600</gtr:issn><gtr:outcomeId>58b457aa6e2969.85424742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B46AE754-68E5-4EBB-8A40-38A231141B5C</gtr:id><gtr:title>Whole-genome sequencing of nine esophageal adenocarcinoma cell lines.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90d437c3480ee74c5cb879507c40c1e7"><gtr:id>90d437c3480ee74c5cb879507c40c1e7</gtr:id><gtr:otherNames>Contino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>58b459c1ebcfc2.68841611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14AB2E8F-226E-42FA-BE2A-41F4B161FD2F</gtr:id><gtr:title>Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival.</gtr:title><gtr:parentPublicationTitle>World journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc945f6233c5051ea1507034d6bc942a"><gtr:id>fc945f6233c5051ea1507034d6bc942a</gtr:id><gtr:otherNames>Talsma AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-2313</gtr:issn><gtr:outcomeId>5436a478ef8142.03289032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0AD10A2-2E7D-4AB8-90D3-250AD39E07D8</gtr:id><gtr:title>Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4635e1c84489b80c09b76bec8d761080"><gtr:id>4635e1c84489b80c09b76bec8d761080</gtr:id><gtr:otherNames>Abrams JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>5436a47779c069.72248135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61A59796-07B8-435E-986E-5FEC57DCC613</gtr:id><gtr:title>The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.</gtr:title><gtr:parentPublicationTitle>Cancer prevention research (Philadelphia, Pa.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c14f7aa93f1e48c0019c13034510a9a2"><gtr:id>c14f7aa93f1e48c0019c13034510a9a2</gtr:id><gtr:otherNames>Couch G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1940-6215</gtr:issn><gtr:outcomeId>58b4583939fb99.06571673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E89C5E8C-5BBF-40AE-84BB-4383F0ABC518</gtr:id><gtr:title>Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77a23e90924b6cb387a5bcd289ef40d"><gtr:id>f77a23e90924b6cb387a5bcd289ef40d</gtr:id><gtr:otherNames>Ong CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8874</gtr:issn><gtr:outcomeId>5436a4773f5604.26067472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBC6F5F1-060D-4252-97BC-998E6D755BA8</gtr:id><gtr:title>Biomarkers in Barrett's Esophagus: Role in Diagnosis, Risk Stratification, and Prediction of Response to Therapy.</gtr:title><gtr:parentPublicationTitle>Gastroenterology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/332aa3c174d2264869cd14658555203a"><gtr:id>332aa3c174d2264869cd14658555203a</gtr:id><gtr:otherNames>Bansal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0889-8553</gtr:issn><gtr:outcomeId>55897f676af379.19488829</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11B46F1B-C87D-4902-AF2A-444FD3139CE6</gtr:id><gtr:title>British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5436a478c450a8.66617625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2DC34C9-ED00-48BA-8944-F2C2D4B62BF0</gtr:id><gtr:title>Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e26b2f9faa40fa69db9b591be1874214"><gtr:id>e26b2f9faa40fa69db9b591be1874214</gtr:id><gtr:otherNames>van der Post RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>978-3-319-41386-0</gtr:isbn><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>58b45a328bf2d9.07731947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A5AD940-022D-4FEE-88E1-DE94292C24C8</gtr:id><gtr:title>Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis.</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d4e381eca74360f552e32796317a15e"><gtr:id>1d4e381eca74360f552e32796317a15e</gtr:id><gtr:otherNames>Katzka DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn><gtr:outcomeId>5436a4764d76c0.86249731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8624FDB4-310D-4223-A714-7D21BB0115BD</gtr:id><gtr:title>Barrett's esophagus and cancer risk: how research advances can impact clinical practice.</gtr:title><gtr:parentPublicationTitle>Gut and liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1976-2283</gtr:issn><gtr:outcomeId>5436a4761acb29.58324697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE47C910-2C6C-4EE2-BB59-66FCE3668FC6</gtr:id><gtr:title>Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>561cce9d884e86.30528736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED78C7E-7132-41DE-9AFB-31CFF23464C0</gtr:id><gtr:title>Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e26b2f9faa40fa69db9b591be1874214"><gtr:id>e26b2f9faa40fa69db9b591be1874214</gtr:id><gtr:otherNames>van der Post RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>978-3-319-41386-0</gtr:isbn><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>58b45aa1bed588.57951047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD9F2053-C795-412A-94F5-27819EB309F9</gtr:id><gtr:title>Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51369dd875ec772c77b28c7d2865e351"><gtr:id>51369dd875ec772c77b28c7d2865e351</gtr:id><gtr:otherNames>Buas MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>5436a475a15943.56849373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41BF2571-5743-4E6A-AD58-3EB80DD42ECA</gtr:id><gtr:title>The use of molecular markers in predicting dysplasia and guiding treatment.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/692964ab766b4dbf3e926adc85942630"><gtr:id>692964ab766b4dbf3e926adc85942630</gtr:id><gtr:otherNames>Zeki S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1521-6918</gtr:issn><gtr:outcomeId>55897f67c6f8e8.11314604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86171919-DF08-4309-A2B4-EB47F2EE173E</gtr:id><gtr:title>The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5436a478000fd0.72021721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02932C60-BE0C-482D-B84B-96BA303AD49C</gtr:id><gtr:title>Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3330f9ef60bad41cfe1f65c9beaae326"><gtr:id>3330f9ef60bad41cfe1f65c9beaae326</gtr:id><gtr:otherNames>Ross-Innes CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>55897f684fc915.53693313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>853EC3E7-A6AD-478C-826A-3D37845ECBAA</gtr:id><gtr:title>Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f8222735008a773ab42a8f486cf0af2"><gtr:id>9f8222735008a773ab42a8f486cf0af2</gtr:id><gtr:otherNames>Gharahkhani P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b403c01fa555.42891833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFE2623C-6B64-4B1E-8686-14F5980DEBD9</gtr:id><gtr:title>Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e68fc401ce88de3505d9e846e3e64f6"><gtr:id>1e68fc401ce88de3505d9e846e3e64f6</gtr:id><gtr:otherNames>Roshandel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5436a475dff9e7.34306461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEAA0027-F65E-40D4-8BD0-E3C1372CBAA0</gtr:id><gtr:title>MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51369dd875ec772c77b28c7d2865e351"><gtr:id>51369dd875ec772c77b28c7d2865e351</gtr:id><gtr:otherNames>Buas MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>55897f673f7667.09648726</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12022/2</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>